Paul Riley/LinkedIn
Jul 18, 2026, 11:54
Paul Riley: Presenting STAR Max3 at ISTH 2026
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared a post on LinkedIn:
“Showing our FDA submission data for the STAR Max3 at ISTH – always a privilege to attend and present at ISTH, with this meeting especially meaningful because it is taking place in Paris, the location for my first ISTH 25 years ago!
A quarter century of being witness to all of the change in the field and also International Society on Thrombosis and Haemostasis (ISTH)‘s growth as an organization clinical laboratory wtd2026.
I really do feel privileged to be involved with ISTH during these times.
I will miss Paris but will make it back soon enough.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment